Gemcitabine in the treatment of advanced transitional cell carcinoma of the urothelium
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/17/suppl_5/v113/477501/mdj964.pdf
Reference61 articles.
1. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a Cooperative Group Study;Loehrer;J Clin Oncol,1992
2. A prospective randomized trial comparing CISCA to MVAC chemotherapy in advanced metastastic urothelial tumors;Logothetis;J Clin Oncol,1990
3. Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma;Bellmunt;Cancer,1997
4. A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract;Hillcoat;J Clin Oncol,1989
5. Combination chemotherapy with cisplatin and methotrexate in advanced transitional cell cancer of the bladder;Stoter;J Urol,1987
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of response to gemcitabine plus cisplatin-based chemotherapy using positron emission computed tomography for metastatic bladder cancer;World Journal of Clinical Cases;2023-12-26
2. LogP of N-acyl-gemcitabine and lectin-corona emerge as key parameters in nanoparticulate intravesical cancer therapy;European Journal of Pharmaceutical Sciences;2023-01
3. Fabrication and evaluation of potentiometric sensors of an anticancer drug (Gemcitabine);European Journal of Chemistry;2020-03-31
4. Maintenance treatment with gemcitabine have a promising activity on metastatic bladder cancer survival;Türk Üroloji Dergisi/Turkish Journal of Urology;2017-08-16
5. Comparing RECIST with EORTC criteria in metastatic bladder cancer;Journal of Cancer Research and Clinical Oncology;2015-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3